Abstract
Chronic viral hepatitis, caused by hepatitis B and hepatitis C viruses, is one of the most common causes of end-stage liver disease and liver cancer in the world, and accounts for almost 4000 deaths per day. Fundamental research in chronic viral hepatitis has led to dramatic changes in its diagnosis, prevention and management. Indeed, the scientists credited with the discovery of hepatitis B (Baruch Blumberg) and hepatitis C (Harvey J. Alter, Michael Houghton and Charles M. Rice) were honoured with the Nobel Prize in 1976 and 2020, respectively. The story of the unravelling of the mysteries behind “serum hepatitis” and the establishment of its viral aetiology is an incredible testament to the remarkable accomplishments of modern biomedical research. In this chapter, we embark on a journey into the discovery of hepatitis B and C viruses, discuss the work of the Nobel laureates and throw light on the work of the unsung heroes without whose contributions, the discoveries may never have seen the light of day.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Almeida JD, Rubenstein D, Stott EJ (1971) New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet 2:1225–1226
Alter HJ (1981) Hepatitis B: a tribute to nondirected medical research. Semin Liver Dis 1:1–6
Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG et al (1972) Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann Intern Med 77:691–699
Alter HJ, Purcell RH, Holland PV, Popper H (1978) Transmissible agent in non-A, non-B hepatitis. Lancet 1:459–463
Bar-Gal GK, Kim MJ, Klein A, Shin DH, Oh CS, Kim JW et al (2012) Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology 56:1671–1680
Baumert TF, Berg T, Lim JK, Nelson DR (2019) Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges. Gastroenterology 156:431–445
Blumberg BS (2002) Hepatitis B: the hunt for a killer virus. Princeton University Press, Princeton and Oxford, pp 72–146
Blumberg BS, Alter HJ, Visnich S (1965) A “new” antigen in leukemia sera. JAMA 191:541–546
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H et al (2019) Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 4:135–184
Dane DS, Cameron CH, Briggs M (1970) Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1:695–698
Dooley DP (2005) History of U.S. military contributions to the study of viral hepatitis. Mil Med 170:71–76
Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292:767–770
Gocke DJ, Greenberg HB, Kavey NB (1970) Correlation of Australia antigen with post-transfusion hepatitis. JAMA 212:877–879
Goel A, Seguy N, Aggarwal R (2019) Burden of hepatitis C virus infection in India: a systematic review and meta-analysis. J Gastroenterol Hepatol (Australia) 34:321–329. https://doi.org/10.1111/jgh.14466
Goldby S (1971) Experiments at the Willowbrook State School. Lancet 1:749
Gruber W, Virchow R (1865) Ueber das Vorkommen und den Nachweis des hepatogenen, insbesondere des katarrhalischen Icterus. Arch Patholog Anat Und Physiol Und Für Klin Med 32:117–125
Khuroo MS, Sofi AA (2020) The discovery of hepatitis viruses: agents and disease. J Clin Exp Hepatol 10:391–401. https://doi.org/10.1016/j.jceh.2020.04.006
Kolykhalov AA, Feinstone SM, Rice CM (1996) Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 70:3363–3371
Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM (1997) Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570–574
Krugman S (1986) The Willowbrook hepatitis studies revisited: ethical aspects. Rev Infect Dis 8:157–162
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113
Lok AS, Zoulim F, Dusheiko G, Ghany MG (2017) Hepatitis B cure: from discovery to regulatory approval. J Hepatol 67(4):847–861
London WT, Sutnick AI, Blumberg B (1969) Australia antigen and acute viral hepatitis. Ann Intern Med 70:55–59
Lürman A (1885) Eine Icterus Epidemic. Berlin Klin Wochenschr 22:207
MacCallum FO (1943) Jaundice in syphilitics. Br J Vener Dis 19:63
MacCallum FO (1947) Homologous serum jaundice. Lancet 2:691–692
Murchison C, ByIhird LB, Fayrer J (1886) Clinical lectures on diseases of the liver, jaundice, and abdominal dropsy. Biomed J Digit Project 31
Prince AM (1968) An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A 60:814–821
Schmidt PJ (1999) Blood: an epic history of medicine and commerce. Transfusion 39:793–793. https://doi.org/10.1046/j.1537-2995.1999.39070793.x
Sood A, Suryaprasad A, Trickey A, Kanchi S, Midha V, Foster MA et al (2018) The burden of hepatitis C virus infection in Punjab, India: a population-based serosurvey. PLoS One 13:1–18. https://doi.org/10.1371/journal.pone.0200461
Stokes JH, Ruedemann R Jr, Lemon WS (1920) Epidemic infectious jaundice and its relation to the therapy of syphilis. Arch Int Med 26:521–543
Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A (1981) A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1(5):377–384
Tabor E, Gerety RJ, Drucker JA et al (1978) Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet 1:463–466
Tanaka T, Kato N, Cho MJ, Sugiyama K, Shimotohno K (1996) Structure of the 3′ terminus of the hepatitis C virus genome. J Virol 70:3307–3312
Tandon BN, Acharya SK, Tandon A (1996) Epidemiology of hepatitis B virus infection in India. Gut 38(Suppl 2):S56–S59
Trepo C (2014) A brief history of hepatitis milestones. Liver Int 34:29–37. https://doi.org/10.1111/liv.12409
Walsh JH, Yalow RS, Berson SA (1970) Radioimmunoassay of Australia antigen. Vox Sang 19(3):217–224
WHO (2017) Global hepatitis report. World Health Organization, Geneva. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf
Wong DT, Martin CM, Boyer JL, Jain D (2015) Historical path of discovery of viral hepatitis. HMSR 3:18–36
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Ethics declarations
All authors have no financial disclosures and declare no conflict of interest.
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
De, A., Chawla, Y.K. (2022). Discovery of Hepatitis Viruses and Two Nobel Prizes: A Tale of Keen Observations, Serendipity, Collaborative Research, Astute Interpretations and Game-Changing Innovations. In: Sobti, R., Ganju, A.K. (eds) Biomedical Translational Research. Springer, Singapore. https://doi.org/10.1007/978-981-16-8845-4_9
Download citation
DOI: https://doi.org/10.1007/978-981-16-8845-4_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-8844-7
Online ISBN: 978-981-16-8845-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)